Evidence map›Paper›PMID 22110380›Full record

ArticleInternational journal of biological sciences2011

Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation.

Giuliana López-Navarrete, Espiridión Ramos-Martínez, Karina Suárez-Álvarez, Jesús Aguirre-García, Yadira Ledezma-Soto, Sonia León-Cabrera, Marco Gudiño-Zayas, Carolina Guzmán, Gabriela Gutiérrez-Reyes, Joselín Hernández-Ruíz and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Pathogenesis of liver cirrhosis.World journal of gastroenterology · 2014
    Review
  19. A Multiscale Agent-Based in silico Model of Liver Fibrosis Progression.Frontiers in bioengineering and biotechnology · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Giuliana López-NavarreteUnidad de Medicina Experimental, Hospital General de México, México D.F. 06726, México.
Espiridión Ramos-Martínez
Karina Suárez-Álvarez
Jesús Aguirre-García
Yadira Ledezma-Soto
Sonia León-Cabrera
Marco Gudiño-Zayas
Carolina Guzmán
Gabriela Gutiérrez-Reyes
Joselín Hernández-Ruíz
Ignacio Camacho-Arroyo
Guillermo Robles-Díaz
David Kershenobich
Luis I Terrazas
Galileo Escobedo
Hospital General de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cirrhosis is the final outcome of liver fibrosis. Kupffer cell-mediated hepatic inflammation is considered to aggravate liver injury and fibrosis. Alternatively-activated macrophages are able to control chronic inflammatory events and trigger wound healing processes. Nevertheless, the role of alternative Kupffer cell activation in liver harm is largely unclear. Thus, we evaluated the participation of alternatively-activated Kupffer cells during liver inflammation and fibrosis in the murine model of carbon tetrachloride-induced hepatic damage. To stimulate alternative activation in Kupffer cells, 20 Taenia crassiceps (Tc) larvae were inoculated into BALBc/AnN female mice. Six weeks post-inoculation, carbon tetrachloride or olive oil were orally administered to Tc-inoculated and non-inoculated mice twice per week during other six weeks. The initial exposure of animals to T. crassiceps resulted in high serum concentrations of IL-4 accompanied by a significant increase in the hepatic mRNA levels of Ym-1, with no alteration in iNOS expression. In response to carbon tetrachloride, recruitment of inflammatory cell populations into the hepatic parenchyma was 5-fold higher in non-inoculated animals than Tc-inoculated mice. In contrast, carbon tetrachloride-induced liver fibrosis was significantly less in non-inoculated animals than in the Tc-inoculated group. The latter showed elevated IL-4 serum levels and low IFN-γ concentrations during the whole experiment, associated with hepatic expression of IL-4, TGF-β, desmin and α-sma, as well as increased mRNA levels of Arg-1, Ym-1, FIZZ-1 and MMR in Kupffer cells. These results suggest that alternative Kupffer cell activation is favored in a Th2 microenvironment, whereby such liver resident macrophages could exhibit a dichotomic role during chronic hepatic damage, being involved in attenuation of the inflammatory response but at the same time exacerbation of liver fibrosis.

Indexed as

ActinsAnimalsEnzyme-Linked Immunosorbent AssayFemaleFibrosisIntercellular Signaling Peptides and ProteinsInterferon-gammaInterleukin-10Interleukin-13Interleukin-4Kupffer CellsLiver CirrhosisMiceNitric Oxide Synthase Type IIReverse Transcriptase Polymerase Chain ReactionTh2 CellsActinsalpha-smooth muscle actin, mouseIntercellular Signaling Peptides and ProteinsInterferon-gammaInterleukin-10Interleukin-13Interleukin-4Nitric Oxide Synthase Type IINos2 protein, mouseRetnla protein, mouseTransforming Growth Factor betaTransforming Growth Factor beta1Tumor Necrosis Factor-alphaalternative macrophage activation.cirrhosisKupffer cellLiver fibrosis

Identifiers

PMID22110380
PMCPMC3221364
OpenAlexW2159397163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.